{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "0c1b574f-3647-4d04-8fa4-61ea1f4a1521",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "data = pd.read_excel(\"./resources/de_jong_et_al_2025_supp_mat.xlsx\", sheet_name=\"Table S5\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "362eb401-f9df-45e3-8c6a-97434201a416",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['cell_status', 'annotation_coarse', 'annotation_granular',\n",
       "       'top_sig_enriched_pathways', 'sig_upreglated_top10'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "fffe6952-933a-486d-bcf0-7af7da3a8329",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cell_status</th>\n",
       "      <th>annotation_coarse</th>\n",
       "      <th>annotation_granular</th>\n",
       "      <th>top_sig_enriched_pathways</th>\n",
       "      <th>sig_upreglated_top10</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Malignant</td>\n",
       "      <td>AC-gliosis-like</td>\n",
       "      <td>AC-gliosis-like 1</td>\n",
       "      <td>['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION',...</td>\n",
       "      <td>['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Malignant</td>\n",
       "      <td>AC-gliosis-like</td>\n",
       "      <td>AC-gliosis-like 2</td>\n",
       "      <td>['GOBP_WOUND_HEALING', 'HALLMARK_EPITHELIAL_ME...</td>\n",
       "      <td>['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2'...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Malignant</td>\n",
       "      <td>AC-gliosis-like</td>\n",
       "      <td>AC-gliosis-like 3</td>\n",
       "      <td>['HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'GOBP_MON...</td>\n",
       "      <td>['LAMA2', 'AC012405.1', 'COL8A1', 'AC007402.1'...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  cell_status annotation_coarse annotation_granular  \\\n",
       "0   Malignant   AC-gliosis-like   AC-gliosis-like 1   \n",
       "1   Malignant   AC-gliosis-like   AC-gliosis-like 2   \n",
       "2   Malignant   AC-gliosis-like   AC-gliosis-like 3   \n",
       "\n",
       "                           top_sig_enriched_pathways  \\\n",
       "0  ['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION',...   \n",
       "1  ['GOBP_WOUND_HEALING', 'HALLMARK_EPITHELIAL_ME...   \n",
       "2  ['HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'GOBP_MON...   \n",
       "\n",
       "                                sig_upreglated_top10  \n",
       "0  ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC...  \n",
       "1  ['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2'...  \n",
       "2  ['LAMA2', 'AC012405.1', 'COL8A1', 'AC007402.1'...  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data[0:3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "ce37ee5d-dff2-4d9f-8deb-6426241de4be",
   "metadata": {},
   "outputs": [],
   "source": [
    "data['plain_query'] = ''\n",
    "data['contextual_query'] = ''\n",
    "data['cell_status_sub'] = data['cell_status'].replace('TME', 'tumour microenvironment')\n",
    "data['annotation_coarse_sub'] = data['annotation_coarse'].replace('AC', 'Astrocyte', regex=True)\n",
    "out = data.to_dict('records')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "6007dba5-f0ee-4aca-865a-38c0e6690725",
   "metadata": {},
   "outputs": [],
   "source": [
    "#gene_list = ['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2', 'AC074351.1', 'DTHD1', 'AC012405.1', 'RTN1', 'MTRNR2L12']\n",
    "#annotated_type = 'astrocyte precursor'\n",
    "\n",
    "for o in out:\n",
    "\n",
    "    o['contextual_query'] = ' '.join([f\"The following is a list of genes enriched in {o['cell_status_sub']} cells from a\",\n",
    "                             \"(human) patient with glioblastoma \",\n",
    "        f\"annotated as {o['annotation_coarse_sub']}. \",\n",
    "        \"What might this list say about the state, properties and interactions of this cell type? \",\n",
    "        \"Do not limit your answers to the cancer literature, \",\n",
    "        \"include normal cell-cell interactions, development and cross-cutting metabolic states. \",\n",
    "        f\"Gene list: {o['sig_upreglated_top10']}\"])\n",
    "\n",
    "    o['plain_query'] = \"What might the following enriched gene lists say about the type, \" \\\n",
    "              f\"properties and cell-cell interactions of the cells the list was derived from { o['sig_upreglated_top10'] }\"\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "6d149e5a-f7a0-4e02-87f7-8f7e972de62b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'cell_status': 'Malignant',\n",
       " 'annotation_coarse': 'AC-gliosis-like',\n",
       " 'annotation_granular': 'AC-gliosis-like 1',\n",
       " 'top_sig_enriched_pathways': \"['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION', 'GOBP_TISSUE_MIGRATION', 'GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION', 'GOBP_ENDOTHELIAL_CELL_MIGRATION']\",\n",
       " 'sig_upreglated_top10': \"['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'cell_status_sub': 'Malignant',\n",
       " 'annotation_coarse_sub': 'Astrocyte-gliosis-like'}"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "out[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "c139366c-f168-4be7-ae0e-5ed84ba6f5a3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Query took 11.69 seconds\n",
      "Query took 17.55 seconds\n",
      "Query took 19.23 seconds\n",
      "Query took 17.58 seconds\n",
      "Query took 12.78 seconds\n",
      "Query took 18.44 seconds\n",
      "Query took 13.56 seconds\n",
      "Query took 17.62 seconds\n",
      "Query took 15.27 seconds\n",
      "Query took 13.82 seconds\n",
      "Query took 23.25 seconds\n",
      "Query took 20.17 seconds\n",
      "Query took 12.56 seconds\n",
      "Query took 18.37 seconds\n",
      "Query took 23.08 seconds\n",
      "Query took 12.71 seconds\n",
      "Query took 15.99 seconds\n",
      "Query took 20.24 seconds\n",
      "Query took 30.91 seconds\n",
      "Query took 24.40 seconds\n",
      "Query took 12.29 seconds\n",
      "Query took 23.88 seconds\n",
      "Query took 26.33 seconds\n",
      "Query took 12.48 seconds\n",
      "Query took 22.52 seconds\n",
      "Query took 13.90 seconds\n",
      "Query took 20.46 seconds\n",
      "Query took 17.08 seconds\n",
      "Query took 8.72 seconds\n",
      "Query took 23.07 seconds\n",
      "Query took 10.84 seconds\n",
      "Query took 12.32 seconds\n",
      "Query took 15.41 seconds\n",
      "Query took 10.33 seconds\n",
      "Query took 30.41 seconds\n",
      "Query took 28.72 seconds\n",
      "Query took 22.74 seconds\n",
      "Query took 19.54 seconds\n",
      "Query took 11.19 seconds\n",
      "Query took 24.66 seconds\n",
      "Query took 12.72 seconds\n",
      "Query took 12.23 seconds\n",
      "Query took 12.66 seconds\n",
      "Query took 16.61 seconds\n",
      "Query took 25.38 seconds\n",
      "Query took 14.26 seconds\n",
      "Query took 10.66 seconds\n",
      "Query took 14.95 seconds\n",
      "Query took 12.60 seconds\n",
      "Query took 19.80 seconds\n",
      "Query took 46.98 seconds\n",
      "Query took 13.08 seconds\n",
      "Query took 12.58 seconds\n",
      "Query took 18.61 seconds\n",
      "Query took 20.77 seconds\n",
      "Query took 13.42 seconds\n",
      "Query took 14.36 seconds\n",
      "Query took 11.20 seconds\n",
      "Query took 20.14 seconds\n",
      "Query took 20.81 seconds\n",
      "Query took 11.26 seconds\n",
      "Query took 21.37 seconds\n",
      "Query took 23.45 seconds\n",
      "Query took 14.35 seconds\n",
      "Query took 24.00 seconds\n",
      "Query took 10.77 seconds\n",
      "Query took 15.45 seconds\n",
      "Query took 10.56 seconds\n",
      "Query took 11.64 seconds\n",
      "Query took 20.76 seconds\n",
      "Query took 18.39 seconds\n",
      "Query took 10.01 seconds\n",
      "Query took 31.82 seconds\n",
      "Query took 12.87 seconds\n",
      "Query took 12.11 seconds\n",
      "Query took 19.82 seconds\n",
      "Query took 22.42 seconds\n",
      "Query took 12.52 seconds\n",
      "Query took 14.28 seconds\n",
      "Query took 12.31 seconds\n",
      "Query took 13.36 seconds\n",
      "Query took 8.34 seconds\n",
      "Query took 27.24 seconds\n",
      "Query took 20.93 seconds\n",
      "Query took 12.27 seconds\n",
      "Query took 34.29 seconds\n",
      "Query took 27.97 seconds\n",
      "Query took 29.88 seconds\n",
      "Query took 11.63 seconds\n",
      "Query took 17.71 seconds\n",
      "Query took 19.82 seconds\n",
      "Query took 12.04 seconds\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import os\n",
    "import time\n",
    "\n",
    "key = os.getenv(\"PERPLEXITY_API_KEY\")\n",
    "\n",
    "url = \"https://api.perplexity.ai/chat/completions\"\n",
    "headers = {\n",
    "    \"accept\": \"application/json\",\n",
    "    \"authorization\": f\"Bearer {key}\",\n",
    "    \"content-type\": \"application/json\"\n",
    "}\n",
    "\n",
    "data = {\n",
    "    \"model\": \"sonar-pro\", # specifying deep search. \n",
    "    \"messages\": [\n",
    "        {\n",
    "            \"role\": \"system\",\n",
    "            \"content\": \"You are an expert biologist. Your answers must be based on primary scientific literature\" \\\n",
    "            \"and major reviews from peer-reviewed sources.\",\n",
    "        },\n",
    "        {\n",
    "            \"role\": \"user\",\n",
    "            \"content\": '',\n",
    "        },\n",
    "    ],\n",
    "#    \"return_citations\": True,  # No longer needed\n",
    "    \"search_mode\": 'academic',\n",
    "    \"stream\": False\n",
    "} \n",
    "\n",
    "for o in out:\n",
    "#    data['messages'][1]['content'] = o['plain_query']\n",
    "#    o['plain_response'] = requests.post(url, headers=headers, json=data)\n",
    "    data['messages'][1]['content'] = o['contextual_query']\n",
    "    start = time.time()\n",
    "    o['contextual_response'] = requests.post(url, headers=headers, json=data)\n",
    "    end = time.time()\n",
    "    print(f\"Query took {end - start:.2f} seconds\")\n",
    "    time.sleep(2.0)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "a2587a66-e190-45b1-9bad-38a8295ee9e8",
   "metadata": {},
   "outputs": [],
   "source": [
    "def gen_bib(bib):\n",
    "    out = ['\\n\\n## References\\n']\n",
    "    index = 1\n",
    "    for ref in bib: \n",
    "        #print(ref.values())\n",
    "        out.append(f\"- [{str(index)}] {' '.join(str(x) for x in ref.values())}\")\n",
    "        index += 1\n",
    "    return '\\n'.join(out)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "45880977-9724-456e-a5bc-8e20fd0d5e94",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'AC-gliosis-like',\n",
       "  'annotation_granular': 'AC-gliosis-like 1',\n",
       "  'top_sig_enriched_pathways': \"['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION', 'GOBP_TISSUE_MIGRATION', 'GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION', 'GOBP_ENDOTHELIAL_CELL_MIGRATION']\",\n",
       "  'sig_upreglated_top10': \"['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Astrocyte-gliosis-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'AC-gliosis-like',\n",
       "  'annotation_granular': 'AC-gliosis-like 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_WOUND_HEALING', 'HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_MICROTUBULE_BASED_MOVEMENT', 'GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION', 'GOBP_EPITHELIAL_CELL_PROLIFERATION']\",\n",
       "  'sig_upreglated_top10': \"['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2', 'AC074351.1', 'DTHD1', 'AC012405.1', 'RTN1', 'MTRNR2L12']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2', 'AC074351.1', 'DTHD1', 'AC012405.1', 'RTN1', 'MTRNR2L12']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2', 'AC074351.1', 'DTHD1', 'AC012405.1', 'RTN1', 'MTRNR2L12']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Astrocyte-gliosis-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'AC-gliosis-like',\n",
       "  'annotation_granular': 'AC-gliosis-like 3',\n",
       "  'top_sig_enriched_pathways': \"['HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'GOBP_MONONUCLEAR_CELL_DIFFERENTIATION', 'HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_RESPONSE_TO_METAL_ION', 'GOBP_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY']\",\n",
       "  'sig_upreglated_top10': \"['LAMA2', 'AC012405.1', 'COL8A1', 'AC007402.1', 'IGFBP7', 'TNC', 'APOLD1', 'CCN1', 'SLC25A18', 'CST3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['LAMA2', 'AC012405.1', 'COL8A1', 'AC007402.1', 'IGFBP7', 'TNC', 'APOLD1', 'CCN1', 'SLC25A18', 'CST3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LAMA2', 'AC012405.1', 'COL8A1', 'AC007402.1', 'IGFBP7', 'TNC', 'APOLD1', 'CCN1', 'SLC25A18', 'CST3']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Astrocyte-gliosis-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'AC-gliosis-like',\n",
       "  'annotation_granular': 'AC-gliosis-like 4',\n",
       "  'top_sig_enriched_pathways': \"['HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_WOUND_HEALING', 'GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY', 'HALLMARK_HYPOXIA']\",\n",
       "  'sig_upreglated_top10': \"['CST3', 'MTRNR2L12', 'SPP1', 'APOE', 'IGFBP7', 'AQP4', 'CHI3L1', 'CRYAB', 'CXCL14', 'VOPP1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['CST3', 'MTRNR2L12', 'SPP1', 'APOE', 'IGFBP7', 'AQP4', 'CHI3L1', 'CRYAB', 'CXCL14', 'VOPP1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['CST3', 'MTRNR2L12', 'SPP1', 'APOE', 'IGFBP7', 'AQP4', 'CHI3L1', 'CRYAB', 'CXCL14', 'VOPP1']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Astrocyte-gliosis-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'AC-progenitor-like',\n",
       "  'annotation_granular': 'AC progenitor-like 1',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION', 'HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION', 'GOBP_WOUND_HEALING', 'HALLMARK_INTERFERON_GAMMA_RESPONSE']\",\n",
       "  'sig_upreglated_top10': \"['CST3', 'AQP4', 'AC074351.1', 'LAMA2', 'TNC', 'COL28A1', 'APOE', 'PTPRT', 'EYA4', 'KLHDC8A']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['CST3', 'AQP4', 'AC074351.1', 'LAMA2', 'TNC', 'COL28A1', 'APOE', 'PTPRT', 'EYA4', 'KLHDC8A']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-progenitor-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['CST3', 'AQP4', 'AC074351.1', 'LAMA2', 'TNC', 'COL28A1', 'APOE', 'PTPRT', 'EYA4', 'KLHDC8A']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Astrocyte-progenitor-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'AC-progenitor-like',\n",
       "  'annotation_granular': 'AC progenitor-like 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_MUSCLE_CELL_PROLIFERATION', 'HALLMARK_INTERFERON_GAMMA_RESPONSE', 'HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_RESPONSE_TO_STEROID_HORMONE', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING']\",\n",
       "  'sig_upreglated_top10': \"['APOE', 'AQP4', 'AC012405.1', 'LINC01088', 'AL355306.2', 'NRG3', 'CFAP54', 'AC002429.2', 'RTN1', 'PLXDC2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['APOE', 'AQP4', 'AC012405.1', 'LINC01088', 'AL355306.2', 'NRG3', 'CFAP54', 'AC002429.2', 'RTN1', 'PLXDC2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-progenitor-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['APOE', 'AQP4', 'AC012405.1', 'LINC01088', 'AL355306.2', 'NRG3', 'CFAP54', 'AC002429.2', 'RTN1', 'PLXDC2']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Astrocyte-progenitor-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'AC-progenitor-like',\n",
       "  'annotation_granular': 'AC progenitor-like 3',\n",
       "  'top_sig_enriched_pathways': \"['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION', 'GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS', 'GOBP_CELL_CELL_SIGNALING_BY_WNT', 'GOBP_WOUND_HEALING']\",\n",
       "  'sig_upreglated_top10': \"['SCN7A', 'AC074351.1', 'LAMA2', 'AC092957.1', 'COL28A1', 'CST3', 'COL25A1', 'IFI44L', 'COL23A1', 'UNC5C']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SCN7A', 'AC074351.1', 'LAMA2', 'AC092957.1', 'COL28A1', 'CST3', 'COL25A1', 'IFI44L', 'COL23A1', 'UNC5C']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-progenitor-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SCN7A', 'AC074351.1', 'LAMA2', 'AC092957.1', 'COL28A1', 'CST3', 'COL25A1', 'IFI44L', 'COL23A1', 'UNC5C']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Astrocyte-progenitor-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'AC-progenitor-like',\n",
       "  'annotation_granular': 'AC progenitor-like 4',\n",
       "  'top_sig_enriched_pathways': \"['HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION', 'GOBP_EPITHELIAL_CELL_PROLIFERATION', 'GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS']\",\n",
       "  'sig_upreglated_top10': \"['TNC', 'TIMP3', 'WARS', 'MTHFD2', 'AC074351.1', 'GDF15', 'PLCG2', 'CST3', 'FBXO32', 'MDM4']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['TNC', 'TIMP3', 'WARS', 'MTHFD2', 'AC074351.1', 'GDF15', 'PLCG2', 'CST3', 'FBXO32', 'MDM4']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-progenitor-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['TNC', 'TIMP3', 'WARS', 'MTHFD2', 'AC074351.1', 'GDF15', 'PLCG2', 'CST3', 'FBXO32', 'MDM4']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Astrocyte-progenitor-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'Gliosis-like',\n",
       "  'annotation_granular': 'Gliosis-like',\n",
       "  'top_sig_enriched_pathways': \"['HALLMARK_HYPOXIA', 'HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'GOBP_WOUND_HEALING', 'GOBP_RESPONSE_TO_OXYGEN_LEVELS']\",\n",
       "  'sig_upreglated_top10': \"['NAMPT', 'VOPP1', 'AKAP12', 'CD44', 'SERPINE1', 'PLCG2', 'TNC', 'LUCAT1', 'MTRNR2L12', 'CHI3L1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['NAMPT', 'VOPP1', 'AKAP12', 'CD44', 'SERPINE1', 'PLCG2', 'TNC', 'LUCAT1', 'MTRNR2L12', 'CHI3L1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['NAMPT', 'VOPP1', 'AKAP12', 'CD44', 'SERPINE1', 'PLCG2', 'TNC', 'LUCAT1', 'MTRNR2L12', 'CHI3L1']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Gliosis-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'Hypoxic',\n",
       "  'annotation_granular': 'Hypoxic 1',\n",
       "  'top_sig_enriched_pathways': \"['HALLMARK_HYPOXIA', 'HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'HALLMARK_MTORC1_SIGNALING', 'HALLMARK_APOPTOSIS', 'HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION']\",\n",
       "  'sig_upreglated_top10': \"['AKAP12', 'NAMPT', 'AC074351.1', 'CD44', 'PLCG2', 'HSPH1', 'DNAJB1', 'CHI3L1', 'HSPA1B', 'MTRNR2L12']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['AKAP12', 'NAMPT', 'AC074351.1', 'CD44', 'PLCG2', 'HSPH1', 'DNAJB1', 'CHI3L1', 'HSPA1B', 'MTRNR2L12']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Hypoxic.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['AKAP12', 'NAMPT', 'AC074351.1', 'CD44', 'PLCG2', 'HSPH1', 'DNAJB1', 'CHI3L1', 'HSPA1B', 'MTRNR2L12']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Hypoxic',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'Hypoxic',\n",
       "  'annotation_granular': 'Hypoxic 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_RESPONSE_TO_OXYGEN_LEVELS', 'GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE', 'GOBP_MUSCLE_SYSTEM_PROCESS', 'HALLMARK_HYPOXIA', 'GOBP_ERK1_AND_ERK2_CASCADE']\",\n",
       "  'sig_upreglated_top10': \"['AL355306.2', 'FN1', 'MDM4', 'AKAP12', 'NOL4', 'DSTYK', 'PLEKHA6', 'GPC5', 'NPTX2', 'ANGPTL4']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['AL355306.2', 'FN1', 'MDM4', 'AKAP12', 'NOL4', 'DSTYK', 'PLEKHA6', 'GPC5', 'NPTX2', 'ANGPTL4']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Hypoxic.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['AL355306.2', 'FN1', 'MDM4', 'AKAP12', 'NOL4', 'DSTYK', 'PLEKHA6', 'GPC5', 'NPTX2', 'ANGPTL4']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Hypoxic',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'NPC-neuronal-like',\n",
       "  'annotation_granular': 'NPC-neuronal-like 1',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_SYNAPSE_ORGANIZATION', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING', 'GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT', 'GOBP_AXON_DEVELOPMENT', 'GOBP_REGULATION_OF_MEMBRANE_POTENTIAL']\",\n",
       "  'sig_upreglated_top10': \"['LRRC7', 'KIRREL3', 'NEGR1', 'ST18', 'CNTN5', 'RBFOX1', 'SEMA3C', 'GRM7', 'AC024230.1', 'RASGEF1B']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['LRRC7', 'KIRREL3', 'NEGR1', 'ST18', 'CNTN5', 'RBFOX1', 'SEMA3C', 'GRM7', 'AC024230.1', 'RASGEF1B']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as NPC-neuronal-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LRRC7', 'KIRREL3', 'NEGR1', 'ST18', 'CNTN5', 'RBFOX1', 'SEMA3C', 'GRM7', 'AC024230.1', 'RASGEF1B']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'NPC-neuronal-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'NPC-neuronal-like',\n",
       "  'annotation_granular': 'NPC-neuronal-like 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_SYNAPSE_ORGANIZATION', 'GOBP_AXON_DEVELOPMENT', 'GOBP_SYNAPSE_ASSEMBLY', 'GOBP_DENDRITE_DEVELOPMENT', 'GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT']\",\n",
       "  'sig_upreglated_top10': \"['DLX6-AS1', 'KIRREL3', 'CNTNAP5', 'CACNA2D3', 'CNTN5', 'PDZRN4', 'EPHB2', 'AC024230.1', 'KLHDC8A', 'NRG1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['DLX6-AS1', 'KIRREL3', 'CNTNAP5', 'CACNA2D3', 'CNTN5', 'PDZRN4', 'EPHB2', 'AC024230.1', 'KLHDC8A', 'NRG1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as NPC-neuronal-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['DLX6-AS1', 'KIRREL3', 'CNTNAP5', 'CACNA2D3', 'CNTN5', 'PDZRN4', 'EPHB2', 'AC024230.1', 'KLHDC8A', 'NRG1']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'NPC-neuronal-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'NPC-neuronal-like',\n",
       "  'annotation_granular': 'NPC-neuronal-like 3',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT', 'GOBP_AXON_DEVELOPMENT', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING', 'GOBP_SYNAPSE_ORGANIZATION', 'GOBP_DENDRITE_DEVELOPMENT']\",\n",
       "  'sig_upreglated_top10': \"['NOL4', 'PLEKHA6', 'ASXL3', 'EBF1', 'AC007100.1', 'ROBO3', 'KLHDC8A', 'EPHB2', 'EPHA3', 'OLFM3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['NOL4', 'PLEKHA6', 'ASXL3', 'EBF1', 'AC007100.1', 'ROBO3', 'KLHDC8A', 'EPHB2', 'EPHA3', 'OLFM3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as NPC-neuronal-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['NOL4', 'PLEKHA6', 'ASXL3', 'EBF1', 'AC007100.1', 'ROBO3', 'KLHDC8A', 'EPHB2', 'EPHA3', 'OLFM3']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'NPC-neuronal-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'NPC-neuronal-like',\n",
       "  'annotation_granular': 'NPC-neuronal-like 4',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_SYNAPSE_ORGANIZATION', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING', 'GOBP_AXON_DEVELOPMENT', 'GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT', 'GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT']\",\n",
       "  'sig_upreglated_top10': \"['PLP1', 'MBP', 'PTGDS', 'NKAIN2', 'RBFOX1', 'ST18', 'LRRC7', 'KIRREL3', 'SPP1', 'SPOCK3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['PLP1', 'MBP', 'PTGDS', 'NKAIN2', 'RBFOX1', 'ST18', 'LRRC7', 'KIRREL3', 'SPP1', 'SPOCK3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as NPC-neuronal-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PLP1', 'MBP', 'PTGDS', 'NKAIN2', 'RBFOX1', 'ST18', 'LRRC7', 'KIRREL3', 'SPP1', 'SPOCK3']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'NPC-neuronal-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'NPC-neuronal-like',\n",
       "  'annotation_granular': 'NPC-neuronal-like 5',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_SYNAPSE_ORGANIZATION', 'GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT', 'GOBP_SYNAPSE_ASSEMBLY', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING', 'GOBP_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION']\",\n",
       "  'sig_upreglated_top10': \"['DLX6-AS1', 'ST18', 'SLC35E3', 'MDM2', 'KIRREL3', 'LRRC7', 'DACH2', 'NRG1', 'NDST4', 'NOL4']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['DLX6-AS1', 'ST18', 'SLC35E3', 'MDM2', 'KIRREL3', 'LRRC7', 'DACH2', 'NRG1', 'NDST4', 'NOL4']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as NPC-neuronal-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['DLX6-AS1', 'ST18', 'SLC35E3', 'MDM2', 'KIRREL3', 'LRRC7', 'DACH2', 'NRG1', 'NDST4', 'NOL4']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'NPC-neuronal-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-NPC-like',\n",
       "  'annotation_granular': 'OPC-NPC-like 1',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_MITOTIC_NUCLEAR_DIVISION', 'GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION', 'HALLMARK_E2F_TARGETS', 'GOBP_CHROMOSOME_SEGREGATION', 'GOBP_NUCLEAR_CHROMOSOME_SEGREGATION']\",\n",
       "  'sig_upreglated_top10': \"['MDM2', 'ARHGAP24', 'NUP107', 'SLC35E3', 'CCDC26', 'PCDH15', 'NOL4', 'AC002069.2', 'LINC02008', 'AL139231.1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['MDM2', 'ARHGAP24', 'NUP107', 'SLC35E3', 'CCDC26', 'PCDH15', 'NOL4', 'AC002069.2', 'LINC02008', 'AL139231.1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-NPC-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['MDM2', 'ARHGAP24', 'NUP107', 'SLC35E3', 'CCDC26', 'PCDH15', 'NOL4', 'AC002069.2', 'LINC02008', 'AL139231.1']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-NPC-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-NPC-like',\n",
       "  'annotation_granular': 'OPC-NPC-like 2',\n",
       "  'top_sig_enriched_pathways': \"['KEGG_PARKINSONS_DISEASE', 'GOBP_CELLULAR_RESPIRATION', 'GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS', 'GOBP_OXIDATIVE_PHOSPHORYLATION', 'GOBP_AEROBIC_RESPIRATION']\",\n",
       "  'sig_upreglated_top10': \"['DACH2', 'CNTN3', 'DACH1', 'TSHR', 'PCDH15', 'TNS3', 'P2RX7', 'SGCD', 'TLL1', 'NEGR1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['DACH2', 'CNTN3', 'DACH1', 'TSHR', 'PCDH15', 'TNS3', 'P2RX7', 'SGCD', 'TLL1', 'NEGR1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-NPC-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['DACH2', 'CNTN3', 'DACH1', 'TSHR', 'PCDH15', 'TNS3', 'P2RX7', 'SGCD', 'TLL1', 'NEGR1']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-NPC-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-NPC-like',\n",
       "  'annotation_granular': 'OPC-NPC-like 3',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING', 'GOBP_SYNAPSE_ORGANIZATION', 'GOBP_REGULATION_OF_MEMBRANE_POTENTIAL', 'GOBP_AXON_DEVELOPMENT', 'GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT']\",\n",
       "  'sig_upreglated_top10': \"['MET', 'PCDH15', 'CAND1', 'CNTNAP2', 'GCFC2', 'AC007389.1', 'MRPL19', 'AC011754.2', 'CPM', 'SLC35E3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['MET', 'PCDH15', 'CAND1', 'CNTNAP2', 'GCFC2', 'AC007389.1', 'MRPL19', 'AC011754.2', 'CPM', 'SLC35E3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-NPC-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['MET', 'PCDH15', 'CAND1', 'CNTNAP2', 'GCFC2', 'AC007389.1', 'MRPL19', 'AC011754.2', 'CPM', 'SLC35E3']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-NPC-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-like',\n",
       "  'annotation_granular': 'OPC-like 1',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT', 'GOBP_AXON_DEVELOPMENT', 'GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT', 'GOBP_CELL_GROWTH', 'GOBP_REGULATION_OF_NEUROGENESIS']\",\n",
       "  'sig_upreglated_top10': \"['SCFD2', 'PDGFRA', 'UBA6-AS1', 'PCDH11X', 'BCAS1', 'LINC02283', 'APOE', 'PCDH15', 'CNTNAP2', 'TNS3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SCFD2', 'PDGFRA', 'UBA6-AS1', 'PCDH11X', 'BCAS1', 'LINC02283', 'APOE', 'PCDH15', 'CNTNAP2', 'TNS3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SCFD2', 'PDGFRA', 'UBA6-AS1', 'PCDH11X', 'BCAS1', 'LINC02283', 'APOE', 'PCDH15', 'CNTNAP2', 'TNS3']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-like',\n",
       "  'annotation_granular': 'OPC-like 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_MEMBRANE_POTENTIAL', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING', 'GOBP_SYNAPSE_ORGANIZATION', 'GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT', 'GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES']\",\n",
       "  'sig_upreglated_top10': \"['LRRN2', 'NOL4', 'MDM4', 'AC007402.1', 'TNS3', 'PDGFRA', 'PCDH15', 'CNTNAP2', 'RBBP5', 'GCFC2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['LRRN2', 'NOL4', 'MDM4', 'AC007402.1', 'TNS3', 'PDGFRA', 'PCDH15', 'CNTNAP2', 'RBBP5', 'GCFC2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LRRN2', 'NOL4', 'MDM4', 'AC007402.1', 'TNS3', 'PDGFRA', 'PCDH15', 'CNTNAP2', 'RBBP5', 'GCFC2']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-like',\n",
       "  'annotation_granular': 'OPC-like 3',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES', 'GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT', 'HALLMARK_E2F_TARGETS', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING', 'GOBP_GLYCOPROTEIN_METABOLIC_PROCESS']\",\n",
       "  'sig_upreglated_top10': \"['SCFD2', 'PDGFRA', 'UBA6-AS1', 'LINC02283', 'PCDH15', 'CEP135', 'PCDH11X', 'TNS3', 'P2RX7', 'DPP10']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SCFD2', 'PDGFRA', 'UBA6-AS1', 'LINC02283', 'PCDH15', 'CEP135', 'PCDH11X', 'TNS3', 'P2RX7', 'DPP10']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SCFD2', 'PDGFRA', 'UBA6-AS1', 'LINC02283', 'PCDH15', 'CEP135', 'PCDH11X', 'TNS3', 'P2RX7', 'DPP10']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-like',\n",
       "  'annotation_granular': 'OPC-like 4',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT', 'GOBP_ENSHEATHMENT_OF_NEURONS', 'GOBP_AXON_DEVELOPMENT', 'GOBP_GLIOGENESIS', 'GOBP_SYNAPSE_ORGANIZATION']\",\n",
       "  'sig_upreglated_top10': \"['TNS3', 'BCAS1', 'P2RX7', 'BMPER', 'PPP1R16B', 'NFASC', 'LINC01170', 'PLP1', 'PCDH11X', 'MBP']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['TNS3', 'BCAS1', 'P2RX7', 'BMPER', 'PPP1R16B', 'NFASC', 'LINC01170', 'PLP1', 'PCDH11X', 'MBP']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['TNS3', 'BCAS1', 'P2RX7', 'BMPER', 'PPP1R16B', 'NFASC', 'LINC01170', 'PLP1', 'PCDH11X', 'MBP']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-like',\n",
       "  'annotation_granular': 'OPC-like 5',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_MEMBRANE_POTENTIAL', 'GOBP_SYNAPSE_ORGANIZATION', 'GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT', 'GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING']\",\n",
       "  'sig_upreglated_top10': \"['PCDH11X', 'NEGR1', 'TAFA1', 'SGCD', 'PCDH15', 'PDGFRA', 'GRM7', 'RBFOX1', 'NOL4', 'ADARB2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['PCDH11X', 'NEGR1', 'TAFA1', 'SGCD', 'PCDH15', 'PDGFRA', 'GRM7', 'RBFOX1', 'NOL4', 'ADARB2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PCDH11X', 'NEGR1', 'TAFA1', 'SGCD', 'PCDH15', 'PDGFRA', 'GRM7', 'RBFOX1', 'NOL4', 'ADARB2']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'OPC-neuronal-like',\n",
       "  'annotation_granular': 'OPC-neuronal-like',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT', 'GOBP_REGULATION_OF_MEMBRANE_POTENTIAL', 'GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING', 'GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT', 'GOBP_SYNAPSE_ORGANIZATION']\",\n",
       "  'sig_upreglated_top10': \"['CNTNAP5', 'MET', 'VGF', 'TENM2', 'POSTN', 'CPM', 'GRM7', 'DPP10', 'HMGA2', 'EPHA3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['CNTNAP5', 'MET', 'VGF', 'TENM2', 'POSTN', 'CPM', 'GRM7', 'DPP10', 'HMGA2', 'EPHA3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as OPC-neuronal-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['CNTNAP5', 'MET', 'VGF', 'TENM2', 'POSTN', 'CPM', 'GRM7', 'DPP10', 'HMGA2', 'EPHA3']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'OPC-neuronal-like',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'Proliferative',\n",
       "  'annotation_granular': 'Proliferative AC-OPC-like',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CHROMOSOME_SEGREGATION', 'GOBP_NUCLEAR_CHROMOSOME_SEGREGATION', 'GOBP_MITOTIC_NUCLEAR_DIVISION', 'GOBP_SISTER_CHROMATID_SEGREGATION', 'HALLMARK_G2M_CHECKPOINT']\",\n",
       "  'sig_upreglated_top10': \"['DIAPH3', 'MIR924HG', 'TOP2A', 'ASPM', 'CENPF', 'APOLD1', 'CENPE', 'MELK', 'CEP135', 'SPC24']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['DIAPH3', 'MIR924HG', 'TOP2A', 'ASPM', 'CENPF', 'APOLD1', 'CENPE', 'MELK', 'CEP135', 'SPC24']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Proliferative.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['DIAPH3', 'MIR924HG', 'TOP2A', 'ASPM', 'CENPF', 'APOLD1', 'CENPE', 'MELK', 'CEP135', 'SPC24']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Proliferative',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'Proliferative',\n",
       "  'annotation_granular': 'Proliferative NPC-OPC-like',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CHROMOSOME_SEGREGATION', 'HALLMARK_E2F_TARGETS', 'HALLMARK_G2M_CHECKPOINT', 'GOBP_NUCLEAR_CHROMOSOME_SEGREGATION', 'GOBP_OXIDATIVE_PHOSPHORYLATION']\",\n",
       "  'sig_upreglated_top10': \"['CENPF', 'CENPE', 'ASPM', 'TOP2A', 'APOLD1', 'NOL4', 'PDGFRA', 'MTRNR2L12', 'EPHB2', 'HIST1H3J']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['CENPF', 'CENPE', 'ASPM', 'TOP2A', 'APOLD1', 'NOL4', 'PDGFRA', 'MTRNR2L12', 'EPHB2', 'HIST1H3J']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Proliferative.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['CENPF', 'CENPE', 'ASPM', 'TOP2A', 'APOLD1', 'NOL4', 'PDGFRA', 'MTRNR2L12', 'EPHB2', 'HIST1H3J']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Proliferative',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'Malignant',\n",
       "  'annotation_coarse': 'Proliferative',\n",
       "  'annotation_granular': 'Proliferative nIPC-like',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CHROMOSOME_SEGREGATION', 'GOBP_MITOTIC_NUCLEAR_DIVISION', 'GOBP_NUCLEAR_CHROMOSOME_SEGREGATION', 'HALLMARK_E2F_TARGETS', 'GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION']\",\n",
       "  'sig_upreglated_top10': \"['COL1A2', 'LINC02008', 'DLX6-AS1', 'KIRREL3', 'AC024230.1', 'PDGFRA', 'EPHB2', 'KLHDC8A', 'SULF1', 'NAMPT']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['COL1A2', 'LINC02008', 'DLX6-AS1', 'KIRREL3', 'AC024230.1', 'PDGFRA', 'EPHB2', 'KLHDC8A', 'SULF1', 'NAMPT']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Proliferative.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['COL1A2', 'LINC02008', 'DLX6-AS1', 'KIRREL3', 'AC024230.1', 'PDGFRA', 'EPHB2', 'KLHDC8A', 'SULF1', 'NAMPT']\",\n",
       "  'cell_status_sub': 'Malignant',\n",
       "  'annotation_coarse_sub': 'Proliferative',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Astrocytes',\n",
       "  'annotation_granular': 'Ambiguous (astrocytes)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION', 'GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT', 'GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE', 'GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT', 'GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION']\",\n",
       "  'sig_upreglated_top10': \"['SLC1A2', 'GPC5', 'ADGRV1', 'ATP1A2', 'GPM6A', 'RYR3', 'PITPNC1', 'RORA', 'CTNNA2', 'HIF3A']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SLC1A2', 'GPC5', 'ADGRV1', 'ATP1A2', 'GPM6A', 'RYR3', 'PITPNC1', 'RORA', 'CTNNA2', 'HIF3A']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Astrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SLC1A2', 'GPC5', 'ADGRV1', 'ATP1A2', 'GPM6A', 'RYR3', 'PITPNC1', 'RORA', 'CTNNA2', 'HIF3A']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Astrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Astrocytes',\n",
       "  'annotation_granular': 'Deep layer astrocytes',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE', 'GOBP_GLUCOCORTICOID_METABOLIC_PROCESS', 'GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE', 'GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT', 'GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT']\",\n",
       "  'sig_upreglated_top10': \"['DPP10', 'ADGRV1', 'GFAP', 'RFX4', 'AQP4', 'PITPNC1', 'SLC1A2', 'ATP1A2', 'SORBS1', 'DTNA']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['DPP10', 'ADGRV1', 'GFAP', 'RFX4', 'AQP4', 'PITPNC1', 'SLC1A2', 'ATP1A2', 'SORBS1', 'DTNA']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Astrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['DPP10', 'ADGRV1', 'GFAP', 'RFX4', 'AQP4', 'PITPNC1', 'SLC1A2', 'ATP1A2', 'SORBS1', 'DTNA']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Astrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Astrocytes',\n",
       "  'annotation_granular': 'Homeostatic astrocytes 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM', 'GOBP_CELL_ADHESION_MOLECULE_PRODUCTION', 'GOBP_CARTILAGE_CONDENSATION', 'GOBP_CELL_AGGREGATION', 'GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS']\",\n",
       "  'sig_upreglated_top10': \"['SLC1A2', 'PTPRZ1', 'GPM6A', 'GPC5', 'RORA', 'CTNNA2', 'DTNA', 'RFX4', 'PITPNC1', 'ATP1A2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SLC1A2', 'PTPRZ1', 'GPM6A', 'GPC5', 'RORA', 'CTNNA2', 'DTNA', 'RFX4', 'PITPNC1', 'ATP1A2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Astrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SLC1A2', 'PTPRZ1', 'GPM6A', 'GPC5', 'RORA', 'CTNNA2', 'DTNA', 'RFX4', 'PITPNC1', 'ATP1A2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Astrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Astrocytes',\n",
       "  'annotation_granular': 'Inflammatory astrocytes 1',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT', 'GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE', 'GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE', 'GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION', 'GOBP_CELLULAR_PIGMENTATION']\",\n",
       "  'sig_upreglated_top10': \"['ADGRV1', 'GPC5', 'SLC1A2', 'PITPNC1', 'RYR3', 'GPM6A', 'DTNA', 'RFX4', 'LINC00299', 'SORBS1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ADGRV1', 'GPC5', 'SLC1A2', 'PITPNC1', 'RYR3', 'GPM6A', 'DTNA', 'RFX4', 'LINC00299', 'SORBS1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Astrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ADGRV1', 'GPC5', 'SLC1A2', 'PITPNC1', 'RYR3', 'GPM6A', 'DTNA', 'RFX4', 'LINC00299', 'SORBS1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Astrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Astrocytes',\n",
       "  'annotation_granular': 'Inflammatory astrocytes 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM', 'GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION', 'GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT', 'GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE', 'GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING']\",\n",
       "  'sig_upreglated_top10': \"['SLC1A2', 'GPC5', 'ADGRV1', 'GPM6A', 'RYR3', 'RORA', 'ATP1A2', 'OBI1-AS1', 'PITPNC1', 'DTNA']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SLC1A2', 'GPC5', 'ADGRV1', 'GPM6A', 'RYR3', 'RORA', 'ATP1A2', 'OBI1-AS1', 'PITPNC1', 'DTNA']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Astrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SLC1A2', 'GPC5', 'ADGRV1', 'GPM6A', 'RYR3', 'RORA', 'ATP1A2', 'OBI1-AS1', 'PITPNC1', 'DTNA']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Astrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Astrocytes',\n",
       "  'annotation_granular': 'Neural-support astrocytes',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT', 'GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE', 'GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION', 'GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT', 'GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS']\",\n",
       "  'sig_upreglated_top10': \"['SLC1A2', 'GPC5', 'ADGRV1', 'ATP1A2', 'GPM6A', 'RYR3', 'PITPNC1', 'LINC00299', 'TPD52L1', 'OBI1-AS1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SLC1A2', 'GPC5', 'ADGRV1', 'ATP1A2', 'GPM6A', 'RYR3', 'PITPNC1', 'LINC00299', 'TPD52L1', 'OBI1-AS1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Astrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SLC1A2', 'GPC5', 'ADGRV1', 'ATP1A2', 'GPM6A', 'RYR3', 'PITPNC1', 'LINC00299', 'TPD52L1', 'OBI1-AS1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Astrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'Ambiguous (lymphocyte)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_CYTOCHROME_C_TO_OXYGEN', 'GOBP_OPSONIZATION', 'GOBP_OXIDATIVE_PHOSPHORYLATION', 'GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS', 'GOBP_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT']\",\n",
       "  'sig_upreglated_top10': \"['SKAP1', 'CD96', 'PARP8', 'PTPRC', 'FYN', 'SLFN12L', 'CBLB', 'CD247', 'IQGAP2', 'SYTL3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SKAP1', 'CD96', 'PARP8', 'PTPRC', 'FYN', 'SLFN12L', 'CBLB', 'CD247', 'IQGAP2', 'SYTL3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SKAP1', 'CD96', 'PARP8', 'PTPRC', 'FYN', 'SLFN12L', 'CBLB', 'CD247', 'IQGAP2', 'SYTL3']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'B cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEUTROPHIL_MEDIATED_IMMUNITY', 'GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY', 'GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS', 'GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY']\",\n",
       "  'sig_upreglated_top10': \"['BANK1', 'BLK', 'RIPOR2', 'RALGPS2', 'MS4A1', 'AFF3', 'EBF1', 'OSBPL10', 'RCSD1', 'ARHGAP15']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['BANK1', 'BLK', 'RIPOR2', 'RALGPS2', 'MS4A1', 'AFF3', 'EBF1', 'OSBPL10', 'RCSD1', 'ARHGAP15']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['BANK1', 'BLK', 'RIPOR2', 'RALGPS2', 'MS4A1', 'AFF3', 'EBF1', 'OSBPL10', 'RCSD1', 'ARHGAP15']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'CD4+ TEM cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_T_HELPER_1_CELL_DIFFERENTIATION', 'GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY', 'GOBP_CYTOLYSIS']\",\n",
       "  'sig_upreglated_top10': \"['PARP8', 'SKAP1', 'PTPRC', 'ARHGAP15', 'STAT4', 'CD96', 'ETS1', 'SYNE2', 'IKZF1', 'THEMIS']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['PARP8', 'SKAP1', 'PTPRC', 'ARHGAP15', 'STAT4', 'CD96', 'ETS1', 'SYNE2', 'IKZF1', 'THEMIS']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PARP8', 'SKAP1', 'PTPRC', 'ARHGAP15', 'STAT4', 'CD96', 'ETS1', 'SYNE2', 'IKZF1', 'THEMIS']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'CD8+ T cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_T_HELPER_1_CELL_DIFFERENTIATION', 'GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION', 'GOBP_CYTOLYSIS']\",\n",
       "  'sig_upreglated_top10': \"['SKAP1', 'PARP8', 'THEMIS', 'CD96', 'PTPRC', 'ARHGAP15', 'STAT4', 'SYTL3', 'SLFN12L', 'PRKCH']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SKAP1', 'PARP8', 'THEMIS', 'CD96', 'PTPRC', 'ARHGAP15', 'STAT4', 'SYTL3', 'SLFN12L', 'PRKCH']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SKAP1', 'PARP8', 'THEMIS', 'CD96', 'PTPRC', 'ARHGAP15', 'STAT4', 'SYTL3', 'SLFN12L', 'PRKCH']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'CD8+ T cells (cytotoxic)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_T_CELL_HOMEOSTASIS', 'GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION', 'GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION']\",\n",
       "  'sig_upreglated_top10': \"['PARP8', 'SKAP1', 'PTPRC', 'THEMIS', 'PRKCH', 'CD96', 'ETS1', 'CBLB', 'SLFN12L', 'ARHGAP15']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['PARP8', 'SKAP1', 'PTPRC', 'THEMIS', 'PRKCH', 'CD96', 'ETS1', 'CBLB', 'SLFN12L', 'ARHGAP15']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PARP8', 'SKAP1', 'PTPRC', 'THEMIS', 'PRKCH', 'CD96', 'ETS1', 'CBLB', 'SLFN12L', 'ARHGAP15']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'Dendritic cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION', 'GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE', 'GOBP_NEUTROPHIL_MEDIATED_IMMUNITY', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY']\",\n",
       "  'sig_upreglated_top10': \"['PTPRC', 'ARHGAP15', 'SKAP1', 'PARP8', 'PRKCH', 'CD96', 'SYTL3', 'IKZF1', 'SP100', 'DOCK8']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['PTPRC', 'ARHGAP15', 'SKAP1', 'PARP8', 'PRKCH', 'CD96', 'SYTL3', 'IKZF1', 'SP100', 'DOCK8']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PTPRC', 'ARHGAP15', 'SKAP1', 'PARP8', 'PRKCH', 'CD96', 'SYTL3', 'IKZF1', 'SP100', 'DOCK8']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'HSP-response T cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS', 'GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE', 'GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY', 'GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION', 'GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE']\",\n",
       "  'sig_upreglated_top10': \"['PARP8', 'SKAP1', 'FYN', 'CD96', 'SYNE2', 'CBLB', 'PITPNC1', 'CD247', 'PTPRC', 'RIPOR2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['PARP8', 'SKAP1', 'FYN', 'CD96', 'SYNE2', 'CBLB', 'PITPNC1', 'CD247', 'PTPRC', 'RIPOR2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PARP8', 'SKAP1', 'FYN', 'CD96', 'SYNE2', 'CBLB', 'PITPNC1', 'CD247', 'PTPRC', 'RIPOR2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'IFN-response T cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_CYTOLYSIS', 'GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY', 'GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION']\",\n",
       "  'sig_upreglated_top10': \"['PARP8', 'SKAP1', 'SYNE2', 'ARHGAP15', 'CD96', 'PTPRC', 'LINC01934', 'SLFN12L', 'STAT4', 'PRKCH']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['PARP8', 'SKAP1', 'SYNE2', 'ARHGAP15', 'CD96', 'PTPRC', 'LINC01934', 'SLFN12L', 'STAT4', 'PRKCH']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PARP8', 'SKAP1', 'SYNE2', 'ARHGAP15', 'CD96', 'PTPRC', 'LINC01934', 'SLFN12L', 'STAT4', 'PRKCH']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'NK cells 1',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CYTOLYSIS', 'GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE', 'GOBP_OPSONIZATION']\",\n",
       "  'sig_upreglated_top10': \"['SKAP1', 'CD247', 'PARP8', 'PTPRC', 'PRKCH', 'SYTL3', 'CD96', 'IQGAP2', 'CBLB', 'MCTP2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SKAP1', 'CD247', 'PARP8', 'PTPRC', 'PRKCH', 'SYTL3', 'CD96', 'IQGAP2', 'CBLB', 'MCTP2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SKAP1', 'CD247', 'PARP8', 'PTPRC', 'PRKCH', 'SYTL3', 'CD96', 'IQGAP2', 'CBLB', 'MCTP2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'NK cells 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CYTOLYSIS', 'GOBP_DENDRITIC_CELL_CHEMOTAXIS', 'GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION', 'GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION', 'GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY']\",\n",
       "  'sig_upreglated_top10': \"['SKAP1', 'CD96', 'CD247', 'MCTP2', 'PARP8', 'PRKCH', 'TXK', 'SYTL3', 'CBLB', 'PTPRC']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SKAP1', 'CD96', 'CD247', 'MCTP2', 'PARP8', 'PRKCH', 'TXK', 'SYTL3', 'CBLB', 'PTPRC']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SKAP1', 'CD96', 'CD247', 'MCTP2', 'PARP8', 'PRKCH', 'TXK', 'SYTL3', 'CBLB', 'PTPRC']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'Naïve T cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY', 'GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY', 'GOBP_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY', 'GOBP_T_HELPER_1_CELL_DIFFERENTIATION', 'GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION']\",\n",
       "  'sig_upreglated_top10': \"['RIPOR2', 'IL7R', 'SKAP1', 'ARHGAP15', 'BCL11B', 'ITK', 'ETS1', 'TXK', 'IKZF1', 'LEF1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['RIPOR2', 'IL7R', 'SKAP1', 'ARHGAP15', 'BCL11B', 'ITK', 'ETS1', 'TXK', 'IKZF1', 'LEF1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['RIPOR2', 'IL7R', 'SKAP1', 'ARHGAP15', 'BCL11B', 'ITK', 'ETS1', 'TXK', 'IKZF1', 'LEF1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'Plasma cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_PROTEIN_DESTABILIZATION', 'GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE', 'GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_II_PROMOTER', 'GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION', 'GOBP_NEPHRON_TUBULE_FORMATION']\",\n",
       "  'sig_upreglated_top10': \"['FCRL5', 'FNDC3B', 'SEL1L3', 'FBXW7', 'IGHG3', 'IGHG1', 'NEDD9', 'IFNG-AS1', 'AC008014.1', 'IGHGP']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['FCRL5', 'FNDC3B', 'SEL1L3', 'FBXW7', 'IGHG3', 'IGHG1', 'NEDD9', 'IFNG-AS1', 'AC008014.1', 'IGHGP']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['FCRL5', 'FNDC3B', 'SEL1L3', 'FBXW7', 'IGHG3', 'IGHG1', 'NEDD9', 'IFNG-AS1', 'AC008014.1', 'IGHGP']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'Proliferatve T cells',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_KINETOCHORE_ORGANIZATION', 'GOBP_G1_TO_G0_TRANSITION', 'GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION', 'GOBP_PROTEIN_LOCALIZATION_TO_CONDENSED_CHROMOSOME', 'GOBP_CENTROMERE_COMPLEX_ASSEMBLY']\",\n",
       "  'sig_upreglated_top10': \"['SKAP1', 'PARP8', 'SLFN12L', 'CD96', 'SYNE2', 'ARHGAP15', 'PTPRC', 'IKZF1', 'TOX', 'IQGAP2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SKAP1', 'PARP8', 'SLFN12L', 'CD96', 'SYNE2', 'ARHGAP15', 'PTPRC', 'IKZF1', 'TOX', 'IQGAP2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SKAP1', 'PARP8', 'SLFN12L', 'CD96', 'SYNE2', 'ARHGAP15', 'PTPRC', 'IKZF1', 'TOX', 'IQGAP2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Lymphocytes',\n",
       "  'annotation_granular': 'T reg',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION', 'GOBP_T_CELL_HOMEOSTASIS', 'GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_REGULATION_OF_MYOBLAST_FUSION', 'GOBP_POST_EMBRYONIC_ANIMAL_ORGAN_DEVELOPMENT']\",\n",
       "  'sig_upreglated_top10': \"['SKAP1', 'SYNE2', 'PTPRC', 'CD247', 'RIPOR2', 'ARHGAP15', 'ITK', 'PRKCH', 'ETS1', 'NIBAN1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SKAP1', 'SYNE2', 'PTPRC', 'CD247', 'RIPOR2', 'ARHGAP15', 'ITK', 'PRKCH', 'ETS1', 'NIBAN1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SKAP1', 'SYNE2', 'PTPRC', 'CD247', 'RIPOR2', 'ARHGAP15', 'ITK', 'PRKCH', 'ETS1', 'NIBAN1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Lymphocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Ambiguous (TAMs)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS', 'GOBP_REGULATION_OF_RESPIRATORY_BURST', 'GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION', 'GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS', 'GOBP_NEUTROPHIL_MEDIATED_IMMUNITY']\",\n",
       "  'sig_upreglated_top10': \"['LRMDA', 'LNCAROD', 'APBB1IP', 'DLEU1', 'FYB1', 'ARHGAP24', 'TBXAS1', 'DOCK8', 'ST6GAL1', 'SLCO2B1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['LRMDA', 'LNCAROD', 'APBB1IP', 'DLEU1', 'FYB1', 'ARHGAP24', 'TBXAS1', 'DOCK8', 'ST6GAL1', 'SLCO2B1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LRMDA', 'LNCAROD', 'APBB1IP', 'DLEU1', 'FYB1', 'ARHGAP24', 'TBXAS1', 'DOCK8', 'ST6GAL1', 'SLCO2B1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Angiogenic TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEUTROPHIL_MEDIATED_IMMUNITY', 'GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS', 'GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS', 'GOBP_BLASTODERM_SEGMENTATION', 'GOBP_THYROID_HORMONE_GENERATION']\",\n",
       "  'sig_upreglated_top10': \"['ABCA1', 'FNDC3B', 'HIF1A-AS3', 'SAT1', 'SLC11A1', 'NRP1', 'DOCK8', 'LUCAT1', 'MSR1', 'CTSB']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ABCA1', 'FNDC3B', 'HIF1A-AS3', 'SAT1', 'SLC11A1', 'NRP1', 'DOCK8', 'LUCAT1', 'MSR1', 'CTSB']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ABCA1', 'FNDC3B', 'HIF1A-AS3', 'SAT1', 'SLC11A1', 'NRP1', 'DOCK8', 'LUCAT1', 'MSR1', 'CTSB']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Anti-inflammatory TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY', 'GOBP_REGULATION_OF_RESPIRATORY_BURST', 'GOBP_NEUTROPHIL_MEDIATED_IMMUNITY', 'GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION']\",\n",
       "  'sig_upreglated_top10': \"['SAT1', 'TBXAS1', 'MERTK', 'CD163', 'MS4A6A', 'MSR1', 'MS4A7', 'SLCO2B1', 'FMN1', 'ARHGAP15']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SAT1', 'TBXAS1', 'MERTK', 'CD163', 'MS4A6A', 'MSR1', 'MS4A7', 'SLCO2B1', 'FMN1', 'ARHGAP15']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SAT1', 'TBXAS1', 'MERTK', 'CD163', 'MS4A6A', 'MSR1', 'MS4A7', 'SLCO2B1', 'FMN1', 'ARHGAP15']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Astrocyte-like TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS', 'GOBP_NEUTROPHIL_MEDIATED_IMMUNITY', 'GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY', 'GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION', 'GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN']\",\n",
       "  'sig_upreglated_top10': \"['LRMDA', 'DOCK8', 'TBXAS1', 'CD74', 'ARHGAP15', 'APBB1IP', 'C3', 'LNCAROD', 'ADAM28', 'FYB1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['LRMDA', 'DOCK8', 'TBXAS1', 'CD74', 'ARHGAP15', 'APBB1IP', 'C3', 'LNCAROD', 'ADAM28', 'FYB1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LRMDA', 'DOCK8', 'TBXAS1', 'CD74', 'ARHGAP15', 'APBB1IP', 'C3', 'LNCAROD', 'ADAM28', 'FYB1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Interferon TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY', 'GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION', 'GOBP_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION', 'GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY']\",\n",
       "  'sig_upreglated_top10': \"['IFI44L', 'DOCK8', 'LRMDA', 'PARP14', 'DLEU1', 'SLC1A3', 'EPSTI1', 'APBB1IP', 'ST6GAL1', 'CHST11']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['IFI44L', 'DOCK8', 'LRMDA', 'PARP14', 'DLEU1', 'SLC1A3', 'EPSTI1', 'APBB1IP', 'ST6GAL1', 'CHST11']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['IFI44L', 'DOCK8', 'LRMDA', 'PARP14', 'DLEU1', 'SLC1A3', 'EPSTI1', 'APBB1IP', 'ST6GAL1', 'CHST11']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Monocytes',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION', 'GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY', 'GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION', 'GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION']\",\n",
       "  'sig_upreglated_top10': \"['SLC11A1', 'SLCO2B1', 'SAT1', 'CD163', 'FYB1', 'LRMDA', 'MSR1', 'LNCAROD', 'C3', 'TBXAS1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SLC11A1', 'SLCO2B1', 'SAT1', 'CD163', 'FYB1', 'LRMDA', 'MSR1', 'LNCAROD', 'C3', 'TBXAS1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SLC11A1', 'SLCO2B1', 'SAT1', 'CD163', 'FYB1', 'LRMDA', 'MSR1', 'LNCAROD', 'C3', 'TBXAS1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Pro-inflammatory TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY', 'GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION', 'GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS', 'GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS']\",\n",
       "  'sig_upreglated_top10': \"['APBB1IP', 'DOCK8', 'ST6GAL1', 'CD74', 'SLC1A3', 'LRMDA', 'OLR1', 'SPP1', 'LPCAT2', 'SRGN']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['APBB1IP', 'DOCK8', 'ST6GAL1', 'CD74', 'SLC1A3', 'LRMDA', 'OLR1', 'SPP1', 'LPCAT2', 'SRGN']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['APBB1IP', 'DOCK8', 'ST6GAL1', 'CD74', 'SLC1A3', 'LRMDA', 'OLR1', 'SPP1', 'LPCAT2', 'SRGN']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Proliferatve TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_RESPIRATORY_BURST', 'GOBP_LEUKOTRIENE_METABOLIC_PROCESS', 'GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS', 'GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION', 'GOBP_RENAL_VESICLE_DEVELOPMENT']\",\n",
       "  'sig_upreglated_top10': \"['LRMDA', 'ARHGAP15', 'DIAPH3', 'FCGBP', 'DOCK8', 'APBB1IP', 'LNCAROD', 'SLC8A1', 'TBXAS1', 'SYK']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['LRMDA', 'ARHGAP15', 'DIAPH3', 'FCGBP', 'DOCK8', 'APBB1IP', 'LNCAROD', 'SLC8A1', 'TBXAS1', 'SYK']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LRMDA', 'ARHGAP15', 'DIAPH3', 'FCGBP', 'DOCK8', 'APBB1IP', 'LNCAROD', 'SLC8A1', 'TBXAS1', 'SYK']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'RTN1+ TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_RESPIRATORY_BURST', 'GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION', 'GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY', 'GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE']\",\n",
       "  'sig_upreglated_top10': \"['LRMDA', 'LNCAROD', 'TBXAS1', 'ARHGAP15', 'USP53', 'SLC8A1', 'FCGBP', 'ATP8B4', 'SFMBT2', 'MSR1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['LRMDA', 'LNCAROD', 'TBXAS1', 'ARHGAP15', 'USP53', 'SLC8A1', 'FCGBP', 'ATP8B4', 'SFMBT2', 'MSR1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LRMDA', 'LNCAROD', 'TBXAS1', 'ARHGAP15', 'USP53', 'SLC8A1', 'FCGBP', 'ATP8B4', 'SFMBT2', 'MSR1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Resident BAM TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY', 'GOBP_NEUTROPHIL_MEDIATED_IMMUNITY', 'GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_II_PROTEIN_COMPLEX', 'GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX']\",\n",
       "  'sig_upreglated_top10': \"['SAT1', 'CD163', 'ACSL1', 'RBM47', 'MSR1', 'SRGN', 'NAMPT', 'LRMDA', 'SLC16A10', 'RAB31']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['SAT1', 'CD163', 'ACSL1', 'RBM47', 'MSR1', 'SRGN', 'NAMPT', 'LRMDA', 'SLC16A10', 'RAB31']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SAT1', 'CD163', 'ACSL1', 'RBM47', 'MSR1', 'SRGN', 'NAMPT', 'LRMDA', 'SLC16A10', 'RAB31']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Resident-TAMs ',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN', 'GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY', 'GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION', 'GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION', 'GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION']\",\n",
       "  'sig_upreglated_top10': \"['CD74', 'APOE', 'C3', 'APBB1IP', 'SLCO2B1', 'ST6GAL1', 'C1QB', 'TBXAS1', 'LRMDA', 'DOCK8']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['CD74', 'APOE', 'C3', 'APBB1IP', 'SLCO2B1', 'ST6GAL1', 'C1QB', 'TBXAS1', 'LRMDA', 'DOCK8']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['CD74', 'APOE', 'C3', 'APBB1IP', 'SLCO2B1', 'ST6GAL1', 'C1QB', 'TBXAS1', 'LRMDA', 'DOCK8']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Myeloid',\n",
       "  'annotation_granular': 'Stress-response TAMs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_DE_NOVO_PROTEIN_FOLDING', 'GOBP_PROTEIN_REFOLDING', 'GOBP_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING', 'GOBP_REGULATION_OF_SPINDLE_ORGANIZATION', 'GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS']\",\n",
       "  'sig_upreglated_top10': \"['HK2', 'GBE1', 'HIF1A-AS3', 'HSPA1A', 'HSPH1', 'HIF1A', 'P4HA1', 'UGCG', 'FNDC3B', 'PLIN2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['HK2', 'GBE1', 'HIF1A-AS3', 'HSPA1A', 'HSPH1', 'HIF1A', 'P4HA1', 'UGCG', 'FNDC3B', 'PLIN2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['HK2', 'GBE1', 'HIF1A-AS3', 'HSPA1A', 'HSPH1', 'HIF1A', 'P4HA1', 'UGCG', 'FNDC3B', 'PLIN2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Myeloid',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Ambiguous (neurons)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME', 'GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME', 'GOBP_NEURONAL_ACTION_POTENTIAL', 'GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM']\",\n",
       "  'sig_upreglated_top10': \"['MEG3', 'CSMD1', 'RBFOX1', 'NRG3', 'SYT1', 'ROBO2', 'KCNIP4', 'NRXN1', 'OPCML', 'CTNNA2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['MEG3', 'CSMD1', 'RBFOX1', 'NRG3', 'SYT1', 'ROBO2', 'KCNIP4', 'NRXN1', 'OPCML', 'CTNNA2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['MEG3', 'CSMD1', 'RBFOX1', 'NRG3', 'SYT1', 'ROBO2', 'KCNIP4', 'NRXN1', 'OPCML', 'CTNNA2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L2-3 IT',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_SENSORY_PERCEPTION_OF_TASTE', 'GOBP_PROTEIN_HETEROOLIGOMERIZATION', 'GOBP_NEURONAL_ACTION_POTENTIAL', 'GOBP_OOCYTE_MATURATION']\",\n",
       "  'sig_upreglated_top10': \"['KCNIP4', 'HS6ST3', 'MEG3', 'CSMD1', 'DLGAP2', 'RBFOX1', 'SYN3', 'IQCJ-SCHIP1', 'LRRTM4', 'AC011287.1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['KCNIP4', 'HS6ST3', 'MEG3', 'CSMD1', 'DLGAP2', 'RBFOX1', 'SYN3', 'IQCJ-SCHIP1', 'LRRTM4', 'AC011287.1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['KCNIP4', 'HS6ST3', 'MEG3', 'CSMD1', 'DLGAP2', 'RBFOX1', 'SYN3', 'IQCJ-SCHIP1', 'LRRTM4', 'AC011287.1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L4 IT',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_QUATERNARY_AMMONIUM_GROUP_TRANSPORT', 'GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH', 'GOBP_MUSCLE_CELL_CELLULAR_HOMEOSTASIS', 'GOBP_PROTEIN_HETEROOLIGOMERIZATION', 'GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS']\",\n",
       "  'sig_upreglated_top10': \"['TSHZ2', 'PTPRT', 'RMST', 'PLCH1', 'RALYL', 'KCNIP4', 'MGAT4C', 'CNTN5', 'DPP10', 'IQCJ-SCHIP1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['TSHZ2', 'PTPRT', 'RMST', 'PLCH1', 'RALYL', 'KCNIP4', 'MGAT4C', 'CNTN5', 'DPP10', 'IQCJ-SCHIP1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['TSHZ2', 'PTPRT', 'RMST', 'PLCH1', 'RALYL', 'KCNIP4', 'MGAT4C', 'CNTN5', 'DPP10', 'IQCJ-SCHIP1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L4-5 IT',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_PROTEIN_HETEROOLIGOMERIZATION', 'GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_T_HELPER_17_CELL_DIFFERENTIATION', 'GOBP_T_CELL_LINEAGE_COMMITMENT', 'GOBP_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT']\",\n",
       "  'sig_upreglated_top10': \"['KCNIP4', 'RALYL', 'SYT1', 'FSTL4', 'IQCJ-SCHIP1', 'OPCML', 'AGBL4', 'RYR2', 'PTPRT', 'CNTN5']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['KCNIP4', 'RALYL', 'SYT1', 'FSTL4', 'IQCJ-SCHIP1', 'OPCML', 'AGBL4', 'RYR2', 'PTPRT', 'CNTN5']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['KCNIP4', 'RALYL', 'SYT1', 'FSTL4', 'IQCJ-SCHIP1', 'OPCML', 'AGBL4', 'RYR2', 'PTPRT', 'CNTN5']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L5 ET',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_MICROTUBULE_NUCLEATION', 'GOBP_CELLULAR_RESPONSE_TO_VITAMIN_D', 'GOBP_NEURONAL_ACTION_POTENTIAL', 'GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE']\",\n",
       "  'sig_upreglated_top10': \"['ROBO2', 'ASIC2', 'DPP10', 'STXBP5L', 'KCNIP4', 'GRIK2', 'NRG1', 'GRM8', 'MEG3', 'CACNA2D3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ROBO2', 'ASIC2', 'DPP10', 'STXBP5L', 'KCNIP4', 'GRIK2', 'NRG1', 'GRM8', 'MEG3', 'CACNA2D3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ROBO2', 'ASIC2', 'DPP10', 'STXBP5L', 'KCNIP4', 'GRIK2', 'NRG1', 'GRM8', 'MEG3', 'CACNA2D3']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L5-6 NP',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM', 'GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH', 'GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE', 'GOBP_POST_EMBRYONIC_ANIMAL_ORGAN_DEVELOPMENT']\",\n",
       "  'sig_upreglated_top10': \"['ZNF385D', 'ASIC2', 'TSHZ2', 'AC068587.4', 'HTR2C', 'MEG3', 'DPP10', 'SNTG1', 'RBFOX1', 'MGAT4C']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ZNF385D', 'ASIC2', 'TSHZ2', 'AC068587.4', 'HTR2C', 'MEG3', 'DPP10', 'SNTG1', 'RBFOX1', 'MGAT4C']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ZNF385D', 'ASIC2', 'TSHZ2', 'AC068587.4', 'HTR2C', 'MEG3', 'DPP10', 'SNTG1', 'RBFOX1', 'MGAT4C']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L6 Car3',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEURONAL_ACTION_POTENTIAL', 'GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_NEURON_FATE_SPECIFICATION', 'GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH']\",\n",
       "  'sig_upreglated_top10': \"['KCNIP4', 'ERC2', 'TMEM132D', 'SYT1', 'ZNF804B', 'SORBS2', 'KCTD16', 'RGS12', 'CADPS', 'MEG3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['KCNIP4', 'ERC2', 'TMEM132D', 'SYT1', 'ZNF804B', 'SORBS2', 'KCTD16', 'RGS12', 'CADPS', 'MEG3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['KCNIP4', 'ERC2', 'TMEM132D', 'SYT1', 'ZNF804B', 'SORBS2', 'KCTD16', 'RGS12', 'CADPS', 'MEG3']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L6 IT',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_REGULATION_OF_VASCULOGENESIS', 'GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_KERATINIZATION', 'GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION']\",\n",
       "  'sig_upreglated_top10': \"['MEG3', 'DPP10', 'RALYL', 'CTNNA2', 'KCNIP4', 'SYT1', 'RYR2', 'CSMD1', 'RBFOX1', 'STXBP5L']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['MEG3', 'DPP10', 'RALYL', 'CTNNA2', 'KCNIP4', 'SYT1', 'RYR2', 'CSMD1', 'RBFOX1', 'STXBP5L']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['MEG3', 'DPP10', 'RALYL', 'CTNNA2', 'KCNIP4', 'SYT1', 'RYR2', 'CSMD1', 'RBFOX1', 'STXBP5L']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L6CT',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL', 'GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION', 'GOBP_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS', 'GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL']\",\n",
       "  'sig_upreglated_top10': \"['DPP10', 'ASIC2', 'KIAA1217', 'RALYL', 'FRMPD4', 'CLSTN2', 'HS3ST4', 'MEG3', 'RYR2', 'CSMD1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['DPP10', 'ASIC2', 'KIAA1217', 'RALYL', 'FRMPD4', 'CLSTN2', 'HS3ST4', 'MEG3', 'RYR2', 'CSMD1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['DPP10', 'ASIC2', 'KIAA1217', 'RALYL', 'FRMPD4', 'CLSTN2', 'HS3ST4', 'MEG3', 'RYR2', 'CSMD1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Exc)',\n",
       "  'annotation_granular': 'Exc L6b',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_RELAXATION_OF_CARDIAC_MUSCLE', 'GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM', 'GOBP_PROTEIN_NITROSYLATION']\",\n",
       "  'sig_upreglated_top10': \"['ROBO2', 'KIAA1217', 'DPP10', 'FRMPD4', 'CACNA2D3', 'SYT1', 'FAM155A', 'MDGA2', 'KALRN', 'RALYL']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ROBO2', 'KIAA1217', 'DPP10', 'FRMPD4', 'CACNA2D3', 'SYT1', 'FAM155A', 'MDGA2', 'KALRN', 'RALYL']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ROBO2', 'KIAA1217', 'DPP10', 'FRMPD4', 'CACNA2D3', 'SYT1', 'FAM155A', 'MDGA2', 'KALRN', 'RALYL']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Exc)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Inh)',\n",
       "  'annotation_granular': 'Inh Chandelier',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEURONAL_ACTION_POTENTIAL', 'GOBP_KERATINIZATION', 'GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_ADAPTATION_OF_SIGNALING_PATHWAY', 'GOBP_RESPONSE_TO_GLUCAGON']\",\n",
       "  'sig_upreglated_top10': \"['ZNF385D', 'CNTN5', 'DPP10', 'THSD7A', 'FSTL5', 'DLGAP2', 'RORA', 'ALK', 'DLGAP1', 'TENM4']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ZNF385D', 'CNTN5', 'DPP10', 'THSD7A', 'FSTL5', 'DLGAP2', 'RORA', 'ALK', 'DLGAP1', 'TENM4']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Inh).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ZNF385D', 'CNTN5', 'DPP10', 'THSD7A', 'FSTL5', 'DLGAP2', 'RORA', 'ALK', 'DLGAP1', 'TENM4']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Inh)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Inh)',\n",
       "  'annotation_granular': 'Inh LAMP5',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_KERATINIZATION', 'GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_PROTEIN_HETEROOLIGOMERIZATION', 'GOBP_RESPONSE_TO_INTERLEUKIN_6', 'GOBP_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION']\",\n",
       "  'sig_upreglated_top10': \"['GRIP1', 'SGCZ', 'GRIK1', 'FGF13', 'PTPRT', 'ADARB2', 'GRIN2A', 'SYT1', 'FGF14', 'MYO16']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['GRIP1', 'SGCZ', 'GRIK1', 'FGF13', 'PTPRT', 'ADARB2', 'GRIN2A', 'SYT1', 'FGF14', 'MYO16']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Inh).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['GRIP1', 'SGCZ', 'GRIK1', 'FGF13', 'PTPRT', 'ADARB2', 'GRIN2A', 'SYT1', 'FGF14', 'MYO16']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Inh)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Inh)',\n",
       "  'annotation_granular': 'Inh PAX6',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_KERATINIZATION', 'GOBP_PROTEIN_HETEROOLIGOMERIZATION', 'GOBP_PHOSPHATIDYLSERINE_METABOLIC_PROCESS', 'GOBP_SENSORY_PERCEPTION_OF_TASTE']\",\n",
       "  'sig_upreglated_top10': \"['ADARB2', 'GRIP1', 'GRIK2', 'RBMS3', 'ZNF385D', 'ROBO2', 'CNTNAP2', 'GABRG3', 'SORCS3', 'SYT1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ADARB2', 'GRIP1', 'GRIK2', 'RBMS3', 'ZNF385D', 'ROBO2', 'CNTNAP2', 'GABRG3', 'SORCS3', 'SYT1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Inh).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ADARB2', 'GRIP1', 'GRIK2', 'RBMS3', 'ZNF385D', 'ROBO2', 'CNTNAP2', 'GABRG3', 'SORCS3', 'SYT1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Inh)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Inh)',\n",
       "  'annotation_granular': 'Inh PVALB',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEURONAL_ACTION_POTENTIAL', 'GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_KERATINIZATION', 'GOBP_RESPONSE_TO_GLUCAGON', 'GOBP_CARTILAGE_CONDENSATION']\",\n",
       "  'sig_upreglated_top10': \"['KIAA1217', 'ZNF385D', 'CNTNAP2', 'KCNC2', 'NXPH1', 'SLIT2', 'GRIP1', 'DLGAP1', 'TENM2', 'ERBB4']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['KIAA1217', 'ZNF385D', 'CNTNAP2', 'KCNC2', 'NXPH1', 'SLIT2', 'GRIP1', 'DLGAP1', 'TENM2', 'ERBB4']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Inh).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['KIAA1217', 'ZNF385D', 'CNTNAP2', 'KCNC2', 'NXPH1', 'SLIT2', 'GRIP1', 'DLGAP1', 'TENM2', 'ERBB4']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Inh)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Inh)',\n",
       "  'annotation_granular': 'Inh RELN',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEURONAL_ACTION_POTENTIAL', 'GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_KERATINIZATION', 'GOBP_REGULATION_OF_MYOTUBE_DIFFERENTIATION', 'GOBP_PROTEIN_HETEROOLIGOMERIZATION']\",\n",
       "  'sig_upreglated_top10': \"['ADARB2', 'CNTN5', 'GRIK2', 'FSTL5', 'INPP4B', 'RGS12', 'CNTNAP2', 'ZNF385D', 'CXCL14', 'DAB1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ADARB2', 'CNTN5', 'GRIK2', 'FSTL5', 'INPP4B', 'RGS12', 'CNTNAP2', 'ZNF385D', 'CXCL14', 'DAB1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Inh).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ADARB2', 'CNTN5', 'GRIK2', 'FSTL5', 'INPP4B', 'RGS12', 'CNTNAP2', 'ZNF385D', 'CXCL14', 'DAB1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Inh)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Inh)',\n",
       "  'annotation_granular': 'Inh SST',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_KERATINIZATION', 'GOBP_RESPONSE_TO_GLUCAGON', 'GOBP_PROTEIN_HETEROOLIGOMERIZATION', 'GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_NEURONAL_ACTION_POTENTIAL']\",\n",
       "  'sig_upreglated_top10': \"['GRIK1', 'ROBO2', 'KIAA1217', 'SYNPR', 'XKR4', 'GRIK2', 'NXPH1', 'GRIP1', 'KIF26B', 'RBFOX1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['GRIK1', 'ROBO2', 'KIAA1217', 'SYNPR', 'XKR4', 'GRIK2', 'NXPH1', 'GRIP1', 'KIF26B', 'RBFOX1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Inh).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['GRIK1', 'ROBO2', 'KIAA1217', 'SYNPR', 'XKR4', 'GRIK2', 'NXPH1', 'GRIP1', 'KIF26B', 'RBFOX1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Inh)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Inh)',\n",
       "  'annotation_granular': 'Inh SST (Chodl)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL', 'GOBP_KERATINIZATION', 'GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION', 'GOBP_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION', 'GOBP_ASYMMETRIC_CELL_DIVISION']\",\n",
       "  'sig_upreglated_top10': \"['NPY', 'GRIK1', 'MPPED2', 'TMTC1', 'NOS1', 'SOX6', 'GRIP1', 'PLCB1', 'TMEM132D', 'SST']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['NPY', 'GRIK1', 'MPPED2', 'TMTC1', 'NOS1', 'SOX6', 'GRIP1', 'PLCB1', 'TMEM132D', 'SST']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Inh).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['NPY', 'GRIK1', 'MPPED2', 'TMTC1', 'NOS1', 'SOX6', 'GRIP1', 'PLCB1', 'TMEM132D', 'SST']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Inh)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Neurons (Inh)',\n",
       "  'annotation_granular': 'Inh VIP',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEURONAL_ACTION_POTENTIAL', 'GOBP_KERATINIZATION', 'GOBP_ANATOMICAL_STRUCTURE_ARRANGEMENT', 'GOBP_RESPONSE_TO_ACIDIC_PH', 'GOBP_PROTEIN_HETEROOLIGOMERIZATION']\",\n",
       "  'sig_upreglated_top10': \"['ADARB2', 'SYNPR', 'GALNTL6', 'ROBO2', 'ERBB4', 'RGS12', 'SNTG1', 'SNHG14', 'CNTNAP2', 'CHRM3']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ADARB2', 'SYNPR', 'GALNTL6', 'ROBO2', 'ERBB4', 'RGS12', 'SNTG1', 'SNHG14', 'CNTNAP2', 'CHRM3']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Inh).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ADARB2', 'SYNPR', 'GALNTL6', 'ROBO2', 'ERBB4', 'RGS12', 'SNTG1', 'SNHG14', 'CNTNAP2', 'CHRM3']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Neurons (Inh)',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'OPCs',\n",
       "  'annotation_granular': 'OPCs',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM', 'GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE', 'GOBP_CARTILAGE_CONDENSATION', 'GOBP_CELL_AGGREGATION', 'GOBP_CEREBELLAR_CORTEX_FORMATION']\",\n",
       "  'sig_upreglated_top10': \"['PTPRZ1', 'TNR', 'LHFPL3', 'PCDH15', 'VCAN', 'MEGF11', 'SOX6', 'LUZP2', 'LRRC4C', 'NRCAM']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['PTPRZ1', 'TNR', 'LHFPL3', 'PCDH15', 'VCAN', 'MEGF11', 'SOX6', 'LUZP2', 'LRRC4C', 'NRCAM']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as OPCs.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PTPRZ1', 'TNR', 'LHFPL3', 'PCDH15', 'VCAN', 'MEGF11', 'SOX6', 'LUZP2', 'LRRC4C', 'NRCAM']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'OPCs',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'OPCs',\n",
       "  'annotation_granular': 'OPCs (differentiating)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE', 'GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING', 'GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION', 'GOBP_REGULATION_OF_FERTILIZATION', 'GOBP_CARDIOBLAST_DIFFERENTIATION']\",\n",
       "  'sig_upreglated_top10': \"['FRY', 'LINC01170', 'CNTN1', 'TNIK', 'KCTD8', 'PTN', 'TMEM132B', 'SGCZ', 'LINC00511', 'PCDH7']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['FRY', 'LINC01170', 'CNTN1', 'TNIK', 'KCTD8', 'PTN', 'TMEM132B', 'SGCZ', 'LINC00511', 'PCDH7']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as OPCs.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['FRY', 'LINC01170', 'CNTN1', 'TNIK', 'KCTD8', 'PTN', 'TMEM132B', 'SGCZ', 'LINC00511', 'PCDH7']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'OPCs',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Oligodendrocytes',\n",
       "  'annotation_granular': 'Ambiguous (oligo.)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE', 'GOBP_CELLULAR_RESPONSE_TO_COPPER_ION', 'GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC', 'GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS', 'GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS']\",\n",
       "  'sig_upreglated_top10': \"['CDH19', 'CRYAB', 'BCAS1', 'SELENOP', 'PTPN13', 'CNTNAP4', 'GALNT15', 'LINC02821', 'SOX2-OT', 'SEMA3C']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['CDH19', 'CRYAB', 'BCAS1', 'SELENOP', 'PTPN13', 'CNTNAP4', 'GALNT15', 'LINC02821', 'SOX2-OT', 'SEMA3C']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Oligodendrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['CDH19', 'CRYAB', 'BCAS1', 'SELENOP', 'PTPN13', 'CNTNAP4', 'GALNT15', 'LINC02821', 'SOX2-OT', 'SEMA3C']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Oligodendrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Oligodendrocytes',\n",
       "  'annotation_granular': 'Oligodendrocytes 1',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE', 'GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC', 'GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS', 'GOBP_KERATINIZATION', 'GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS']\",\n",
       "  'sig_upreglated_top10': \"['MOBP', 'APOD', 'CRYAB', 'BCAS1', 'SOX2-OT', 'ERBB4', 'OPALIN', 'AC012494.1', 'PTPRD', 'NLGN1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['MOBP', 'APOD', 'CRYAB', 'BCAS1', 'SOX2-OT', 'ERBB4', 'OPALIN', 'AC012494.1', 'PTPRD', 'NLGN1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Oligodendrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['MOBP', 'APOD', 'CRYAB', 'BCAS1', 'SOX2-OT', 'ERBB4', 'OPALIN', 'AC012494.1', 'PTPRD', 'NLGN1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Oligodendrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Oligodendrocytes',\n",
       "  'annotation_granular': 'Oligodendrocytes 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION', 'GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC', 'GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE', 'GOBP_GROOMING_BEHAVIOR', 'GOBP_ORGANISM_EMERGENCE_FROM_PROTECTIVE_STRUCTURE']\",\n",
       "  'sig_upreglated_top10': \"['MOBP', 'AC008571.2', 'CNTNAP4', 'BCAS1', 'AC012494.1', 'AC090015.1', 'PTPRD', 'SOX2-OT', 'PDE1A', 'RASGRF2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['MOBP', 'AC008571.2', 'CNTNAP4', 'BCAS1', 'AC012494.1', 'AC090015.1', 'PTPRD', 'SOX2-OT', 'PDE1A', 'RASGRF2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Oligodendrocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['MOBP', 'AC008571.2', 'CNTNAP4', 'BCAS1', 'AC012494.1', 'AC090015.1', 'PTPRD', 'SOX2-OT', 'PDE1A', 'RASGRF2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Oligodendrocytes',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'Ambiguous (vascular)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM', 'GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS', 'GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS', 'GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY', 'GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION']\",\n",
       "  'sig_upreglated_top10': \"['RBMS3', 'IGFBP7', 'PTPRG', 'TIMP3', 'LHFPL6', 'COBLL1', 'EPAS1', 'CALD1', 'PTPRM', 'LAMA2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['RBMS3', 'IGFBP7', 'PTPRG', 'TIMP3', 'LHFPL6', 'COBLL1', 'EPAS1', 'CALD1', 'PTPRM', 'LAMA2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['RBMS3', 'IGFBP7', 'PTPRG', 'TIMP3', 'LHFPL6', 'COBLL1', 'EPAS1', 'CALD1', 'PTPRM', 'LAMA2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'Endothelial (CNA-associated)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY', 'GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM', 'GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS', 'GOBP_REGULATION_OF_HISTONE_DEACETYLATION', 'GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION']\",\n",
       "  'sig_upreglated_top10': \"['IGFBP7', 'VWF', 'PTPRG', 'PTPRZ1', 'EGFR', 'GALNT18', 'ABCB1', 'ANGPT2', 'SPARC', 'PLEKHG1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['IGFBP7', 'VWF', 'PTPRG', 'PTPRZ1', 'EGFR', 'GALNT18', 'ABCB1', 'ANGPT2', 'SPARC', 'PLEKHG1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['IGFBP7', 'VWF', 'PTPRG', 'PTPRZ1', 'EGFR', 'GALNT18', 'ABCB1', 'ANGPT2', 'SPARC', 'PLEKHG1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'Endothelial (Other)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_HYPOTHALAMUS_DEVELOPMENT', 'GOBP_SURFACTANT_HOMEOSTASIS', 'GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE', 'GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY', 'GOBP_T_HELPER_1_CELL_DIFFERENTIATION']\",\n",
       "  'sig_upreglated_top10': \"['HSPG2', 'VWF', 'COL4A2', 'IGFBP7', 'FLT1', 'ANGPT2', 'COL4A1', 'ADGRF5', 'PLEKHG1', 'NOTCH4']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['HSPG2', 'VWF', 'COL4A2', 'IGFBP7', 'FLT1', 'ANGPT2', 'COL4A1', 'ADGRF5', 'PLEKHG1', 'NOTCH4']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['HSPG2', 'VWF', 'COL4A2', 'IGFBP7', 'FLT1', 'ANGPT2', 'COL4A1', 'ADGRF5', 'PLEKHG1', 'NOTCH4']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'Endothelial (arteriole)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE_SPINDLE_ASSEMBLY_CHECKPOINT', 'GOBP_T_HELPER_1_CELL_DIFFERENTIATION', 'GOBP_ERYTHROCYTE_DEVELOPMENT', 'GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT', 'GOBP_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS']\",\n",
       "  'sig_upreglated_top10': \"['MECOM', 'RBMS3', 'VWF', 'EPAS1', 'PTPRG', 'PTPRB', 'ARL15', 'ERG', 'PTPRM', 'PECAM1']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['MECOM', 'RBMS3', 'VWF', 'EPAS1', 'PTPRG', 'PTPRB', 'ARL15', 'ERG', 'PTPRM', 'PECAM1']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['MECOM', 'RBMS3', 'VWF', 'EPAS1', 'PTPRG', 'PTPRB', 'ARL15', 'ERG', 'PTPRM', 'PECAM1']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'Endothelial (capillary)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_HISTONE_H3_ACETYLATION', 'GOBP_ERYTHROCYTE_DEVELOPMENT', 'GOBP_HYPOTHALAMUS_DEVELOPMENT', 'GOBP_ACTIN_FILAMENT_BASED_TRANSPORT', 'GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT']\",\n",
       "  'sig_upreglated_top10': \"['ABCB1', 'ATP10A', 'MECOM', 'EPAS1', 'VWF', 'PTPRG', 'MYRIP', 'PTPRB', 'COBLL1', 'ERG']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ABCB1', 'ATP10A', 'MECOM', 'EPAS1', 'VWF', 'PTPRG', 'MYRIP', 'PTPRB', 'COBLL1', 'ERG']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ABCB1', 'ATP10A', 'MECOM', 'EPAS1', 'VWF', 'PTPRG', 'MYRIP', 'PTPRB', 'COBLL1', 'ERG']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'Endothelial (venule)',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_T_HELPER_1_CELL_DIFFERENTIATION', 'GOBP_ERYTHROCYTE_DEVELOPMENT', 'GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY', 'GOBP_AMINE_CATABOLIC_PROCESS', 'GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION']\",\n",
       "  'sig_upreglated_top10': \"['ABCB1', 'VWF', 'EPAS1', 'PLEKHG1', 'FLT1', 'RBMS3', 'MECOM', 'ERG', 'PTPRG', 'ANO2']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['ABCB1', 'VWF', 'EPAS1', 'PLEKHG1', 'FLT1', 'RBMS3', 'MECOM', 'ERG', 'PTPRG', 'ANO2']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ABCB1', 'VWF', 'EPAS1', 'PLEKHG1', 'FLT1', 'RBMS3', 'MECOM', 'ERG', 'PTPRG', 'ANO2']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'Pericytes 1',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION', 'GOBP_PROTEIN_ACTIVATION_CASCADE', 'GOBP_RELAXATION_OF_CARDIAC_MUSCLE', 'GOBP_RELAXATION_OF_MUSCLE', 'GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS']\",\n",
       "  'sig_upreglated_top10': \"['IGFBP7', 'EBF1', 'CALD1', 'PRKG1', 'FN1', 'COBLL1', 'COL4A2', 'ITGA1', 'RBMS3', 'SLC38A11']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['IGFBP7', 'EBF1', 'CALD1', 'PRKG1', 'FN1', 'COBLL1', 'COL4A2', 'ITGA1', 'RBMS3', 'SLC38A11']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['IGFBP7', 'EBF1', 'CALD1', 'PRKG1', 'FN1', 'COBLL1', 'COL4A2', 'ITGA1', 'RBMS3', 'SLC38A11']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'Pericytes 2',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS', 'GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS', 'GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM', 'GOBP_REGULATION_OF_HISTONE_DEACETYLATION', 'GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE']\",\n",
       "  'sig_upreglated_top10': \"['IGFBP7', 'COL4A1', 'CALD1', 'FN1', 'PTPRZ1', 'LHFPL6', 'RBMS3', 'COL4A2', 'SOX5', 'PTPRG']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['IGFBP7', 'COL4A1', 'CALD1', 'FN1', 'PTPRZ1', 'LHFPL6', 'RBMS3', 'COL4A2', 'SOX5', 'PTPRG']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['IGFBP7', 'COL4A1', 'CALD1', 'FN1', 'PTPRZ1', 'LHFPL6', 'RBMS3', 'COL4A2', 'SOX5', 'PTPRG']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>},\n",
       " {'cell_status': 'TME',\n",
       "  'annotation_coarse': 'Vascular-associated',\n",
       "  'annotation_granular': 'VLMC',\n",
       "  'top_sig_enriched_pathways': \"['GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE_SPINDLE_ASSEMBLY_CHECKPOINT', 'GOBP_MIDDLE_EAR_MORPHOGENESIS', 'GOBP_REGULATION_OF_CELL_CYCLE_CHECKPOINT', 'GOBP_CARDIAC_MYOFIBRIL_ASSEMBLY', 'GOBP_PROTEIN_ACTIVATION_CASCADE']\",\n",
       "  'sig_upreglated_top10': \"['LAMA2', 'RBMS3', 'SVIL', 'PARD3', 'RORA', 'BICC1', 'AC092957.1', 'COL1A2', 'F3', 'LINC01088']\",\n",
       "  'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['LAMA2', 'RBMS3', 'SVIL', 'PARD3', 'RORA', 'BICC1', 'AC092957.1', 'COL1A2', 'F3', 'LINC01088']\",\n",
       "  'contextual_query': \"The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LAMA2', 'RBMS3', 'SVIL', 'PARD3', 'RORA', 'BICC1', 'AC092957.1', 'COL1A2', 'F3', 'LINC01088']\",\n",
       "  'cell_status_sub': 'tumour microenvironment',\n",
       "  'annotation_coarse_sub': 'Vascular-associated',\n",
       "  'contextual_response': <Response [200]>}]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "out"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "5aae5932-7625-4321-a3b4-a0dd371c5d8c",
   "metadata": {},
   "outputs": [],
   "source": [
    "def rep(fu, typ):\n",
    "    print(typ + '_response')\n",
    "    print(type(fu))\n",
    "    print(type(fu[typ + '_response']))\n",
    "    r = fu[typ + '_response']\n",
    "    j = r.json()\n",
    "    title = f\"# {typ} query { fu['annotation_granular'] }\"\n",
    "    q = fu[typ + '_query']\n",
    "    query = f\"Query: {q}\"\n",
    "    content = j['choices'][0]['message']['content']\n",
    "    bib = gen_bib(j['search_results'])\n",
    "    return \"\\n\\n\".join([title, query, content, bib])\n",
    "\n",
    "def generate_report(row):\n",
    "    return \"\\n\\n\".join([rep(row, typ ='plain'), rep(row, typ='contextual')])\n",
    "\n",
    "def generate_reports(records, directory_path):\n",
    "    for r in records:\n",
    "        plain_filename = f\"{directory_path}{r['annotation_granular']}_plain.md\"\n",
    "        contextual_filename = f\"{directory_path}{r['annotation_granular']}_contextual.md\"\n",
    "\n",
    "#        with open(plain_filename, 'w') as file:\n",
    "#            file.write(rep(r, 'plain'))\n",
    "\n",
    "        with open(contextual_filename, 'w') as file:\n",
    "            file.write(rep(r, 'contextual')) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "cc92603a-e3c2-4d82-beeb-1fc72877f1c3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['id', 'model', 'created', 'usage', 'citations', 'search_results', 'object', 'choices'])"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "out[0]['contextual_response'].json().keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "0db75cca-4560-46bc-9508-9cb701c570f4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "plain_response\n",
      "<class 'dict'>\n"
     ]
    },
    {
     "ename": "KeyError",
     "evalue": "'plain_response'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mKeyError\u001b[39m                                  Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[19]\u001b[39m\u001b[32m, line 4\u001b[39m\n\u001b[32m      2\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mrich\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mconsole\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Console\n\u001b[32m      3\u001b[39m console = Console()\n\u001b[32m----> \u001b[39m\u001b[32m4\u001b[39m console.print(Markdown(\u001b[43mgenerate_report\u001b[49m\u001b[43m(\u001b[49m\u001b[43mout\u001b[49m\u001b[43m[\u001b[49m\u001b[32;43m0\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m)\u001b[49m))\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[18]\u001b[39m\u001b[32m, line 15\u001b[39m, in \u001b[36mgenerate_report\u001b[39m\u001b[34m(row)\u001b[39m\n\u001b[32m     14\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mgenerate_report\u001b[39m(row):\n\u001b[32m---> \u001b[39m\u001b[32m15\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[33m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[33m\"\u001b[39m.join([\u001b[43mrep\u001b[49m\u001b[43m(\u001b[49m\u001b[43mrow\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtyp\u001b[49m\u001b[43m \u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m'\u001b[39;49m\u001b[33;43mplain\u001b[39;49m\u001b[33;43m'\u001b[39;49m\u001b[43m)\u001b[49m, rep(row, typ=\u001b[33m'\u001b[39m\u001b[33mcontextual\u001b[39m\u001b[33m'\u001b[39m)])\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[18]\u001b[39m\u001b[32m, line 4\u001b[39m, in \u001b[36mrep\u001b[39m\u001b[34m(fu, typ)\u001b[39m\n\u001b[32m      2\u001b[39m \u001b[38;5;28mprint\u001b[39m(typ + \u001b[33m'\u001b[39m\u001b[33m_response\u001b[39m\u001b[33m'\u001b[39m)\n\u001b[32m      3\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;28mtype\u001b[39m(fu))\n\u001b[32m----> \u001b[39m\u001b[32m4\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;28mtype\u001b[39m(\u001b[43mfu\u001b[49m\u001b[43m[\u001b[49m\u001b[43mtyp\u001b[49m\u001b[43m \u001b[49m\u001b[43m+\u001b[49m\u001b[43m \u001b[49m\u001b[33;43m'\u001b[39;49m\u001b[33;43m_response\u001b[39;49m\u001b[33;43m'\u001b[39;49m\u001b[43m]\u001b[49m))\n\u001b[32m      5\u001b[39m r = fu[typ + \u001b[33m'\u001b[39m\u001b[33m_response\u001b[39m\u001b[33m'\u001b[39m]\n\u001b[32m      6\u001b[39m j = r.json()\n",
      "\u001b[31mKeyError\u001b[39m: 'plain_response'"
     ]
    }
   ],
   "source": [
    "from rich.markdown import Markdown\n",
    "from rich.console import Console\n",
    "console = Console()\n",
    "console.print(Markdown(generate_report(out[0])))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "2f70da7f-9de2-44fd-8986-b463ed14e9c9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n",
      "contextual_response\n",
      "<class 'dict'>\n",
      "<class 'requests.models.Response'>\n"
     ]
    }
   ],
   "source": [
    "generate_reports(out, './output/pro/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e11a30f5-e977-4dc2-8ea5-accbf44a22f0",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
